• Latest Posts

French Oncolytic Virus Vaccine for Breast Cancer enters Phase II

UPDATE: Norwegian Stock Exchange hits Record Biotech IPO

Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

You Can Now Search Worldwide Genomic Data in a Single Platform

Interview 23 Mar 2017

Meet the CEO of this Intrepid Spanish Biotech exploring Epigenetics

ADVERTISEMENT
Interview 20 Mar 2017

Immuno-oncology is Overcrowded – Here is Where Startups Can Succeed

Interview 16 Mar 2017

“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”

Interview 6 Mar 2017

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

There’s a New Record in Biotech Fundraising: Should We Believe the Hype?

What are the Current Challenges in the Booming Field of ADCs?

In the Age of Biological Therapeutics, Chemists move to ADCs

ADVERTISEMENT